A subpopulation of dopamine D1 receptors mediate repetitive jaw movements in rats

Arnt, 1985, Antistereotypic effects of dopamine D1 and D2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity, Naunyn-Schmiedeberg's Arch. Pharmacol., 336, 97, 10.1007/BF00499901 Billard, 1984, Characterization of the binding of 3H-SCH 23390, a selective D1 receptor agonist ligand in rat striatum, Life Sci., 35, 1885, 10.1016/0024-3205(84)90540-X Bzowej, 1988, Dopamine D1 receptors with enhanced agonist affinity and reduced antagonist affinity revealed by chemical modifications, Biochem. Biophys. Res. Comm., 152, 933, 10.1016/S0006-291X(88)80130-X Clow, 1979, Changes in dopamine mediated behavior during one year's neuroleptic administration, Eur. J. Pharmacol., 57, 365, 10.1016/0014-2999(79)90499-0 Daly, 1991, The new selective D1 receptor agonist A68930: Pharmacological characterization in relation to D1: D2 interaction, Brit. J. Pharmacol., 104, 60P Daly, 1992, D1 dopamine receptors and the topography of unconditioned motor behavior: Studies with the selective “full efficacy” benzazepine D-1 agonist SKF 83189, J. Psychopharmacol., 6, 50, 10.1177/026988119200600111 Hamblin, 1983, Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2- dihydroxyquinoline, Life Sci., 32, 2247, 10.1016/0024-3205(83)90423-X Heffner, 1980, A rapid method for the regional dissection of the rat brain, Pharmacol. Biochem. Behav., 13, 453, 10.1016/0091-3057(80)90254-3 Hess, 1987, Differential modification of striatal D1 and D2 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2- dihydroxyquinoline in vivo and in vitro, Mol. Pharmacol., 31, 50 Johansson, 1987, Opposite effects of a D1 and D2 agonist on oral movements in rats, Eur. J. Pharmacol., 134, 83, 10.1016/0014-2999(87)90134-8 Koshikawa, 1987, Sulpiride injection into the dorsal striatum increases metamphetamine-induced gnawing in rats, Eur. J. Pharmacol., 133, 119, 10.1016/0014-2999(87)90213-5 Koshikawa, 1989, Effects of intrastriatal injection of selective dopamine D1 and D2 agonists and antagonists on jaw movements in rats, Eur. J. Pharmacol., 163, 227, 10.1016/0014-2999(89)90191-X Koshikawa, 1990, Dopamine D-1 but not D-2 receptor stimulation of the dorsal striatum potentiates apomorphine-induced jaw movements in rats, Eur. J. Pharmacol., 178, 189, 10.1016/0014-2999(90)90474-K Meller, 1985, Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroxyquinoline in vivo. Selective protection by neuroleptics, J. Pharmacol. Exp. Ther., 233, 656 Molloy, 1984, Dopaminergic behavior stereospecifically promoted by the D1 agonist R-SKF 38393 and selectively blocked by the D1 antagonist SCH 23390, Psychopharmacology (Berl.), 82, 409, 10.1007/BF00427697 Murray, 1991, Age related changes in the regulation of behavior by D-1:D-2 dopamine receptor interactions, Neurobiol. Aging, 12, 431, 10.1016/0197-4580(91)90069-V Rosengarten, 1983, Induction of oral dyskinesia in naive rats by D1-stimulation, Life Sci., 33, 2479, 10.1016/0024-3205(83)90155-8 Rosengarten, 1986, Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats, Life Sci., 39, 29, 10.1016/0024-3205(86)90434-0 Rosengarten, 1988, Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements, Adv. Exp. Med. Biol., 235, 159, 10.1007/978-1-4899-2723-1_11 Rosengarten, 1989, A full repetitive jaw movement response after 70% depletion of caudate D1 receptors, Pharmacol. Biochem. Behav., 34, 895, 10.1016/0091-3057(89)90290-6 Stoof, 1981, Opposing roles for the D-1 and D-2 dopamine receptors, Nature, 294, 366, 10.1038/294366a0